Fingerprint
Dive into the research topics where Kumudha Balakrishnan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma
Sarkar, A., Stellrecht, C., Vangapandu, H. V., Ayres, M., Kaipparettu, B. A., Park, J. H., Balakrishnan, K., Burks, J. K., Pandita, T. K., Hittelman, W. N., Neelapu, S. S. & Gandhi, V., Feb 2021, In: Haematologica. 106, 2, p. 495-512 18 p.Research output: Contribution to journal › Article › peer-review
Open Access27 Link opens in a new tab Scopus citations -
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity
Chu, F., Li, H. S., Liu, X., Cao, J., Ma, W., Ma, Y., Weng, J., Zhu, Z., Cheng, X., Wang, Z., Liu, J., Jiang, Z. Y., Luong, A. U., Peng, W., Wang, J., Balakrishnan, K., Yee, C., Dong, C., Davis, R. E. & Watowich, S. S. & 1 others, , Nov 1 2019, In: Leukemia. 33, 11, p. 2640-2653 14 p.Research output: Contribution to journal › Article › peer-review
55 Link opens in a new tab Scopus citations -
Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents
Chen, W., Fan, H., Balakrishnan, K., Wang, Y., Sun, H., Fan, Y., Gandhi, V., Arnold, L. A. & Peng, X., Oct 25 2018, In: Journal of Medicinal Chemistry. 61, 20, p. 9132-9145 14 p.Research output: Contribution to journal › Article › peer-review
53 Link opens in a new tab Scopus citations -
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy
Patel, V. K., Lamothe, B., Ayres, M. L., Gay, J., Cheung, J. P., Balakrishnan, K., Ivan, C., Morse, J., Nelson, M., Keating, M. J., Wierda, W. G., Marszalek, J. R. & Gandhi, V., Apr 1 2018, In: Leukemia. 32, 4, p. 920-930 11 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Link opens in a new tab Scopus citations -
A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL
Jain, N., Balakrishnan, K., Ferrajoli, A., O'Brien, S. M., Burger, J. A., Kadia, T. M., Cortes, J. E., Ayres, M. L., Tambaro, F. P., Keating, M. J., Gandhi, V. & Wierda, W. G., 2017, In: Oncotarget. 8, 13, p. 22104-22112 9 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations